Background: Growing evidence have indicated that cell cycle-related genes (CRGs) play an
essential role in the progression of pancreatic adenocarcinoma (PAAD). Nevertheless, the …

The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the
lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing …

The 5-year overall survival (OS) of pancreatic ductal adenocarcinoma (PDAC) is only 10%,
partly owing to the lack of reliable diagnostic and prognostic biomarkers. The raw gene-cell …

Pancreatic ductal adenocarcinoma (PDAC) is recognized as a highly aggressive fatal
disease accounting for more than 90% of all pancreatic malignancies. Considering the …

Background Improved usage of the repertoires of pancreatic ductal adenocarcinoma
(PDAC) profiles is crucially needed to guide the development of predictive and prognostic …

Aim To identify novel candidate genes for pancreatic cancer. Methods We performed a
transcriptome‐wide association study (TWAS) analysis of pancreatic cancer (PC). GWAS …

Background: Pancreatic ductal adenocarcinoma (PDAC) is a truly devastating disease,
primarily due to late diagnosis when curative resection is no longer possible and the lack of …

Background Pancreatic cancer is associated with high mortality and is one of the most
aggressive of malignancies, but studies have not fully evaluated its molecular subtypes …

Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most invasive solid
malignancies. Immunotherapy and targeted therapy confirmed an existing certain curative …

The current investigation aimed to mine therapeutic molecular targets that play an key part in
the advancement of pancreatic ductal adenocarcinoma (PDAC). The expression profiling by …